What is the best therapy for Whipple's disease? Our point of view

被引:7
作者
Biagi, Federico [1 ]
Biagi, Gian Luigi [2 ]
Corazza, Gino Roberto [1 ]
机构
[1] Univ Pavia, Dept Internal Med 1, Fdn IRCCS Policlin San Matteo, Pavia, Italy
[2] Univ Bologna, Dept Pharmacol, Bologna, Italy
关键词
Ceftriaxone; doxycycline; trimethoprim-sulfamethoxazole; Tropheryma whipplei; Whipple's disease; TROPHERYMA-WHIPPLEI; TRIMETHOPRIM-SULFAMETHOXAZOLE; TETRACYCLINES; EFFICACY; RELAPSE; MALARIA;
D O I
10.1080/00365521.2016.1264009
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Although Whipple's disease (WD) has been treated with antibiotics since the early 50s, the best antibiotics and the duration of the therapy have not yet been established. We consider here the pro and cons of the two most commonly used therapies, ceftriaxone followed by trimethoprim-sulfamethoxazole (TMP-SMZ) and hydroxychloroquine in combination with doxycycline. The therapy based on ceftriaxone and TMP-SMZ is efficient in the vast majority of patients for the first few years. However, since reinfections or reactivations can occur, a life-long prophylaxis is necessary and doxycycline is nowadays the best option. We thus propose a therapy based on merging these to therapies together, ceftriaxone, and TMP-SMZ for the first year(s) and then life-long prophylaxis with doxycycline.
引用
收藏
页码:465 / 466
页数:2
相关论文
共 21 条
  • [1] Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines
    Agwuh, Kenneth N.
    MacGowan, Alasdair
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (02) : 256 - 265
  • [2] Acquired resistance to trimethoprim-sulfamethoxazole during Whipple disease and expression of the causative target gene
    Bakkali, Nawal
    Fenollar, Florence
    Biswas, Silpak
    Rolain, Jean-Marc
    Raoult, Didier
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2008, 198 (01): : 101 - 108
  • [3] Cytokine genetic profile in Whipple's disease
    Biagi, F.
    Badulli, C.
    Feurle, G. E.
    Mueller, C.
    Moos, V.
    Schneider, T.
    Marth, T.
    Mytilineos, J.
    Garlaschelli, F.
    Marchese, A.
    Trotta, L.
    Bianchi, P. I.
    Di Stefano, M.
    Cremaschi, A. L.
    De Silvestri, A.
    Salvaneschi, L.
    Martinetti, M.
    Corazza, G. R.
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2012, 31 (11) : 3145 - 3150
  • [4] Chambers H., 2006, Goodman Gilman's - The Pharmacological Basis of Therapeutics, P1173
  • [5] Efficacy and safety of pharmacological treatments for acute Lyme neuroborreliosis - a systematic review
    Dersch, R.
    Freitag, M. H.
    Schmidt, S.
    Sommer, H.
    Rauer, S.
    Meerpohl, J. J.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 (09) : 1249 - 1259
  • [6] Concentrations of doxycycline in cerebrospinal fluid in Whipple's disease
    Dubourg, Gregory
    Lagier, Jean-Christophe
    Armstrong, Nicholas
    Richez, Magali
    Chabriere, Eric
    Raoult, Didier
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2015, 45 (06) : 677 - 678
  • [7] Intrafamilial Circulation of Tropheryma whipplei, France
    Fenollar, Florence
    Keita, Alpha K.
    Buffet, Sylvain
    Raoult, Didier
    [J]. EMERGING INFECTIOUS DISEASES, 2012, 18 (06) : 949 - 955
  • [8] Efficacy of Ceftriaxone or Meropenem as Initial Therapies in Whipple's Disease
    Feurle, Gerhard E.
    Junga, Natascha S.
    Marth, Thomas
    [J]. GASTROENTEROLOGY, 2010, 138 (02) : 478 - 486
  • [9] Tetracyclines in malaria
    Gaillard, Tiphaine
    Madamet, Marylin
    Pradines, Bruno
    [J]. MALARIA JOURNAL, 2015, 14
  • [10] Considerations when prescribing trimethoprim-sulfamethoxazole
    Ho, Joanne M. -W.
    Juurlink, David N.
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2011, 183 (16) : 1851 - 1858